Sort
15,842 grants matching “pancreatic cancer”
Inhibition of Pancreatic Cancer by New PPARgamma Agonis*
$203,615Stephen H Safe · Texas A&M University · R01 · FY2007 · CA
Adaptable hydrogel platform to study pancreatic cancer
$203,580Chien-Chi Lin · Indiana University Indianapolis · R21 · FY2015 · CA
Transglutaminase Modulated Tumor-Stroma Interaction in Pancreatic Cancer
$203,580Daniela E Matei · Indiana University Indianapolis · R21 · FY2012 · CA
A new energy restriction mimetic that targets pancreatic cancer
$203,580Susan Lanza-Jacoby · Thomas Jefferson University · R21 · FY2015 · CA
Ligand-Receptor Interactions in the TGF-beta superfamily
$203,570Andrew P Hinck · University Of Texas Hlth Science Center · R01 · FY2009 · GM
Photodynamic Priming for Bidirectional Modulation of Drug Transport Across the Blood-Brain Tumor Barrier
$203,530Huang Chiao Huang · Univ Of Maryland, College Park · R21 · FY2020 · EB
Project #2
$203,490Tamaro Syton Hudson · Howard University · U54 · FY2025 · CA
(PQ1) Cellular senescence as an initiating event in malignant transformation
$203,400Gregory David · New York University School Of Medicine · R21 · FY2017 · CA
Screening Markers for Persons with High Pancreatic Cancer Susceptibility
$203,387Michael G. Goggins · Johns Hopkins University · P50 · FY2010 · CA
Deployable Endoluminal Ultrasound Phased Array for Precision Treatment of Pancreatic Cancer
$203,379Chris John Diederich · University Of California, San Francisco · R21 · FY2019 · CA
Targeting asymmetric ciliary signaling in cancer
$203,363Erica A Golemis · Research Inst Of Fox Chase Can Ctr · R21 · FY2020 · CA
Preclinical Validation of U1 Adaptors for Suppression of KRAS in Pancreatic Cancer
$203,337Samuel I Gunderson · Rutgers, The State Univ Of N.J. · R21 · FY2015 · CA
Modeling muscle wasting in cancer cachexia
$203,280Denis C Guttridge · Ohio State University · R21 · FY2016 · AR
Targeting crosstalk between insulin and Gq signaling systems in pancreatic cancer
$203,280Juan Enrique Rozengurt · University Of California Los Angeles · R21 · FY2010 · CA
Clinical Photodynamic Therapy for Pancreatic and Biliary Tract Cancer
$203,248Stephen Pereira · Massachusetts General Hospital · P01 · FY2011 · CA
Alcohol Abuse and Metabolic Syndrome Promote Desmoplasia of Pancreatic Cancer
$203,218Stephen J Pandol · University Of California Los Angeles · P01 · FY2014 · CA
Predicting the diagnosis of pancreatic cancer by leveraging big data
$203,197Christie Younghae Jeon · Cedars-Sinai Medical Center · R21 · FY2018 · CA
R21 MPI microRNA directed therapy for treating early stage pancreatic cancer
$203,188Fan Zhang · University Of Florida · R21 · FY2024 · CA
Inefficient autophagy, mitochondrial dysfunction, and pancreatic tumorigenesis
$203,151Anna S Gukovskaya · University Of California Los Angeles · P01 · FY2015 · CA
Identification of inhibitors of hedgehog autoprocessing
$203,000Henry Paulus · Boston Biomedical Research Institute · R21 · FY2009 · NS
Combination Therapy: Targeting Pancreatic Cancer with a ROS Inducer and Gemcitabine
$202,991Katie Reindl · North Dakota State University · P20 · FY2019 · GM
Fundamentals of Early and Variant Pancreatic Neoplasia
$202,962Anirban Maitra · Johns Hopkins University · P50 · FY2011 · CA
Optical probe for microscopic cancer identification in minute structures
$202,929Martin Feldman · Louisiana State Univ A&M Col Baton Rouge · R21 · FY2009 · CA
Development and Dissemination of KiNet: A Novel Imaging Informatics Tool for Gastrointestinal and Pancreatic Neuroendocrine Tumors
$202,928Fuyong Xing · University Of Colorado Denver · R21 · FY2020 · CA
Phase 1 study to test safety and dose of proglumide as an anti-fibrotic agent
$202,928Jill P Smith · Georgetown University · R21 · FY2019 · CA